PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
Ireland
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
United Kingdom
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
Germany
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
Italy
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
France
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
PHARMACEUTICAL COMPOSITION COMPRISING HOST CELLS ENCODING ANTI-NY-ESO-1 T CELL RECEPTORS
Spain
20201340.5
Filed on 2020-10-12
20201340.5
Filed on 2020-10-12
Anti-Human Papillomavirus 16 E7 T Cell Receptors
Australia
2024266702
Filed on 2024-11-19
2024266702
Filed on 2024-11-19
Delivery Of Packaged RNA To Mammalian Cells
Luxembourg
19207297.3
Filed on 2019-11-05
19207297.3
Filed on 2019-11-05
Delivery Of Packaged RNA To Mammalian Cells
The Netherlands
19207297.3
Filed on 2019-11-05
19207297.3
Filed on 2019-11-05
Delivery Of Packaged RNA To Mammalian Cells
Switzerland
19207297.3
Filed on 2019-11-05
19207297.3
Filed on 2019-11-05